Lori Bruce first joined Yale’s Interdisciplinary Center for Bioethics in 2011 as assistant director of its summer program. She became director of the program and associate director of the center in 2016.
In recent years, she has successfully spurred The U.S. Department of Health and Human Services to issue new guidance to teaching hospitals and medical schools requiring that providers obtain consent before performing sensitive examinations, particularly on patients under anesthesia; worked with states to improve their infant abandonment laws and increase support and confidentiality for pregnant and postpartum women; and called for caution, consent, and long-term support for patients as states have begun to legalize forms of psychedelic medicine.
In July, Bruce succeeded Stephen Latham as director of the center, which is supported by the Institution for Social and Policy Studies, following his retirement from the position after 15 years. Now, as the center’s third director, Bruce hopes to strengthen its role in ethical policymaking, expand its global reach, and help bring the tools of bioethics into more professions and communities.
In a recent conversation, Bruce reflected on her introduction to bioethics, the lessons she brought from neuroscience and crisis counseling, and the importance of approaching ethical questions with collaboration and humility. The interview has been edited and condensed.
How did you first become involved in bioethics?
I was running a social neurosciences lab at Harvard, and I was also providing rape crisis counseling in the Boston area. I would meet with survivors when they came to the hospital for post-assault care. I would not know their name or anything about them. I just knew they were showing up for care.
My role was to help create a buffer between the survivors and the hospital system because the emergency departments were not equipped to address their unique needs alone. We helped survivors understand the forensic and medical services available to them and the implications of their choices within the justice system. The survivors’ control had just been ripped from them, so we were there to help them reclaim their power and get connected to support services.
You are describing a delicate situation with much complexity and many ethical considerations.
Yes, and because of that work, I was asked to join the first community ethics committee at Harvard. The committee leaders wanted to amplify the voices and values of community members in health policy across the Harvard system.
Was that a logical transition for you?
I first asked the committee’s founder, Carol Powers, “Whose ethics matter to you?” I was skeptical of how community views would be gathered, for whose purpose, and whether we would have a say in how our voices were represented. She and I engaged in a series of discussions around consent, power, goodness, authority, and what “care” really means within health care. I was impressed by how carefully she listened and how her responses were influenced by both her own personal experiences within hospitals and her understanding of broader social and economic factors. That was my introduction to bioethics.
“Whose voices matter?” is a question I continue to pose throughout my work and frequently discuss with my students. More importantly, whose voices ought to matter? There is often a distinction between those questions. As bioethicists, we can sometimes help smooth out power imbalances, helping physicians or patients and families ensure that their voices are articulated and integrated within solutions.
What did you think of bioethics when you first encountered it?
I had no idea what they were talking about. I was wary of this idea of bioethics because I thought, “Who is anyone to say what is ethical?
I had no familiarity with modern bioethics as a social movement that arose in the 1960s, in part from the civil rights movement. Carol Powers invited me to be part of the community ethics group, and that opened doors for me to attend bioethics training programs at Harvard while I was still working in social neuroscience.
What was that training like?
At the time, bioethics education was often delivered through short courses in which people reflected on principles — including dignity, justice, and autonomy — and then applied those principles to bedside consults or policies. I kept asking, “How are you getting from here to there?”
My previous experience was very methodological and structured. I came from a computer science and neuroscience background, and when you analyze computer code — or the brain — you follow a process to ensure you are not making mistakes. I was baffled at the lack of structure within bioethical deliberations. There were these ethereal values and principles, and somehow we were supposed to jump from them to policy recommendations.
Much of my work has been influenced by those early days, when I was always seeking a process.